H Lundbeck A/S Cash Flow Conversion Efficiency

Latest as of December 2025: 0.014x

H Lundbeck A/S cash flow conversion efficiency. Based on the latest financial reports, H Lundbeck A/S (HLUN-A) has a cash flow conversion efficiency ratio of 0.014x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Dkr338.00 Million ≈ $52.88 Million USD) by net assets (Dkr24.90 Billion ≈ $3.90 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of H Lundbeck A/S (2004–2025)

Cash flow conversion efficiency of H Lundbeck A/S from 2004 to 2025. This chart illustrates how H Lundbeck A/S's cash flow conversion efficiency has evolved over time, based on yearly financial data. View HLUN-A live share price for real-time trading data and today's change.

H Lundbeck A/S Cash Flow Conversion Ratio Explained

H Lundbeck A/S cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

H Lundbeck A/S Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of H Lundbeck A/S ranked by their cash flow conversion efficiency. Also see how much is H Lundbeck A/S worth for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
DUERR AG UNSP.ADR 1/5
F:DUEB
0.117x
Hansol Chemica
KO:014680
0.061x
Central Securities Corporation
NYSE MKT:CET
0.006x
ORG Packaging Co Ltd
SHE:002701
0.068x
Advtech
JSE:ADH
0.311x
IGNITIS GRUPE SP.GDR/1
F:IGV
0.048x
Metrovacesa SA
MC:MVC
0.099x
BGF Retail Co Ltd
KO:282330
0.188x

Annual Cash Flow Conversion Efficiency for H Lundbeck A/S (2004–2025)

The table below shows the annual cash flow conversion efficiency of H Lundbeck A/S from 2004 to 2025. Review HLUN-A cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 Dkr24.90 Billion
≈ $3.90 Billion
Dkr4.90 Billion
≈ $766.33 Million
0.197x +47.90%
2024-12-31 Dkr25.01 Billion
≈ $3.91 Billion
Dkr3.33 Billion
≈ $520.38 Million
0.133x -28.14%
2023-12-31 Dkr22.05 Billion
≈ $3.45 Billion
Dkr4.08 Billion
≈ $638.35 Million
0.185x +9.28%
2022-12-31 Dkr20.78 Billion
≈ $3.25 Billion
Dkr3.52 Billion
≈ $550.57 Million
0.169x +36.25%
2021-12-31 Dkr18.28 Billion
≈ $2.86 Billion
Dkr2.27 Billion
≈ $355.47 Million
0.124x -45.02%
2020-12-31 Dkr16.97 Billion
≈ $2.66 Billion
Dkr3.84 Billion
≈ $600.33 Million
0.226x +26.11%
2019-12-31 Dkr14.55 Billion
≈ $2.28 Billion
Dkr2.61 Billion
≈ $408.20 Million
0.179x -57.29%
2018-12-31 Dkr14.25 Billion
≈ $2.23 Billion
Dkr5.98 Billion
≈ $935.77 Million
0.420x +26.38%
2017-12-31 Dkr12.18 Billion
≈ $1.91 Billion
Dkr4.04 Billion
≈ $632.87 Million
0.332x +2.98%
2016-12-31 Dkr9.69 Billion
≈ $1.52 Billion
Dkr3.13 Billion
≈ $489.09 Million
0.322x +1338.01%
2015-12-31 Dkr8.79 Billion
≈ $1.37 Billion
Dkr197.00 Million
≈ $30.82 Million
0.022x -81.16%
2014-12-31 Dkr13.53 Billion
≈ $2.12 Billion
Dkr1.61 Billion
≈ $251.90 Million
0.119x -57.32%
2013-12-31 Dkr13.48 Billion
≈ $2.11 Billion
Dkr3.76 Billion
≈ $588.28 Million
0.279x +74.29%
2012-12-31 Dkr13.20 Billion
≈ $2.06 Billion
Dkr2.11 Billion
≈ $330.44 Million
0.160x -43.59%
2011-12-31 Dkr12.78 Billion
≈ $2.00 Billion
Dkr3.62 Billion
≈ $567.00 Million
0.284x -3.37%
2010-12-31 Dkr11.12 Billion
≈ $1.74 Billion
Dkr3.27 Billion
≈ $510.83 Million
0.294x -14.82%
2009-12-31 Dkr8.80 Billion
≈ $1.38 Billion
Dkr3.03 Billion
≈ $474.69 Million
0.345x -5.88%
2008-12-31 Dkr7.59 Billion
≈ $1.19 Billion
Dkr2.78 Billion
≈ $434.98 Million
0.366x -2.72%
2007-12-31 Dkr7.18 Billion
≈ $1.12 Billion
Dkr2.70 Billion
≈ $423.19 Million
0.376x +82.69%
2006-12-31 Dkr6.76 Billion
≈ $1.06 Billion
Dkr1.39 Billion
≈ $218.10 Million
0.206x -25.47%
2005-12-31 Dkr7.49 Billion
≈ $1.17 Billion
Dkr2.07 Billion
≈ $324.10 Million
0.277x -19.06%
2004-12-31 Dkr7.84 Billion
≈ $1.23 Billion
Dkr2.68 Billion
≈ $418.96 Million
0.342x --

About H Lundbeck A/S

CO:HLUN-A Denmark Drug Manufacturers - Specialty & Generic
Market Cap
$1.56 Billion
Dkr9.95 Billion DKK
Market Cap Rank
#6801 Global
#42 in Denmark
Share Price
Dkr50.00
Change (1 day)
+1.32%
52-Week Range
Dkr31.65 - Dkr50.00
All Time High
Dkr50.00
About

H. Lundbeck A/S engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally. The company offers Abilify Maintena/ Abilify Asimtufii for schizophrenia and bipolar I disorder in adults; Brintellix/Trintellix to treat depressive disorders; Rexulti/Rxulti to treat maj… Read more